about
A Proposal for a Study on Treatment Selection and Lifestyle Recommendations in Chronic Inflammatory Diseases: A Danish Multidisciplinary Collaboration on Prognostic Factors and Personalised Medicine.Blockade of Tumor Necrosis Factor-Alpha: A Role for Adalimumab in Neovascular Age-Related Macular Degeneration Refractory to Anti-Angiogenesis Therapy?Role of agonistic autoantibodies against type-1 angiotensin II receptor in the pathogenesis of retinopathy in preeclampsia.Treatment prescribing patterns in patients with juvenile idiopathic arthritis (JIA): Analysis from the UK Childhood Arthritis Prospective Study (CAPS).Efficacy and safety of adalimumab in Behçet's disease-related uveitis: a multicenter retrospective observational study.Efficacy of Anti-TNF-α Therapy for the Treatment of Non-infectious Uveitis: A Retrospective Study of 21 Patients.An Update on Treatment of Pediatric Chronic Non-Infectious Uveitis.Simvastatin as an Adjunct to Conventional Therapy of Non-infectious Uveitis: A Randomized, Open-Label Pilot Study.Oxidative stress and reactive oxygen species: a review of their role in ocular disease.Modern Therapeutic Approaches for Noninfectious Ocular Diseases Involving Inflammation.Successful ustekinumab treatment of noninfectious uveitis and concomitant severe psoriatic arthritis and plaque psoriasis.Adalimumab for the treatment of refractory noninfectious paediatric uveitis.Intravitreal Adalimumab for the Control of Breakthrough Intraocular Inflammation.Effects of Hyriopsis cumingii Polysaccharides on Mice Immunologic Receptor, Transcription Factor, and Cytokine.Theissenolactone C Exhibited Ocular Protection of Endotoxin-Induced Uveitis by Attenuating Ocular Inflammatory Responses and Glial Activation.Outcome of Juvenile Idiopathic Arthritis Associated Uveitis in Two Disease Subtypes
P2860
Q33749513-0394C84F-6DFF-403C-8B3A-08F82ACD8F51Q36766273-AE1A881C-1146-461A-9CC7-4B88D3151FADQ37067705-91D356CD-762A-4054-B745-6B32333BCCF1Q37313894-9E57A6C1-D0B8-4AE4-B68E-22DD6CA4FEAAQ39181648-C70CC030-48B2-46B3-8AB1-30F1EF798AECQ40488997-79C47227-EB79-46CD-BF84-5BA586BE4F9CQ41994612-10C57531-8614-4E02-9C31-E4EEFF566397Q41995275-BBBA8D77-EA13-4EF2-9207-E7A02E419D47Q46248374-12057F71-D93D-4F59-897C-492B71057312Q47442388-0CEB2747-B734-4FDA-8FC2-70642A04C6B4Q48189498-A98352D8-BC09-466E-883E-4949D1EB64DBQ48554997-03D4B8FF-BA0F-40E5-B40D-9F44D7BE7693Q50091416-5CE9CD98-3943-410E-A002-874D18A536E1Q51380530-5F0C2018-3A3F-426A-B0C3-6D8ADE8E604AQ55253194-979B90B1-3A3A-4815-9092-5962E2415F31Q58134161-E9A047CB-EA59-405D-96AE-8AFD2581A949
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Anti-tumor necrosis factor-α therapy in uveitis.
@en
type
label
Anti-tumor necrosis factor-α therapy in uveitis.
@en
prefLabel
Anti-tumor necrosis factor-α therapy in uveitis.
@en
P1476
Anti-tumor necrosis factor-α therapy in uveitis.
@en
P2093
Miguel Cordero-Coma
P304
P356
10.1016/J.SURVOPHTHAL.2015.06.004
P50
P577
2015-07-08T00:00:00Z